News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
630,020 Results
Type
Article (61324)
Company Profile (84)
Press Release (568612)
Section
Business (173534)
Career Advice (2713)
Deals (32398)
Drug Delivery (80)
Drug Development (76779)
Employer Resources (150)
FDA (14810)
Job Trends (13861)
News (304766)
Policy (29385)
Tag
Academia (2868)
Africa (873)
Alliances (42833)
Alzheimer's disease (1089)
Approvals (14747)
Arizona (123)
Artificial intelligence (68)
Asia (37120)
Australia (6663)
Bankruptcy (281)
Best Places to Work (10522)
Biosimilars (59)
Biotechnology (60)
C2C Services and Suppliers (67509)
California (1543)
Canada (824)
Cancer (439)
Career advice (2291)
Cell therapy (121)
China (125)
Clinical research (59955)
Collaboration (121)
Colorado (68)
Connecticut (62)
COVID-19 (2476)
Cystic fibrosis (71)
Data (272)
Diabetes (73)
Diagnostics (5767)
Drug pricing (65)
Earnings (57613)
Employer resources (130)
Europe (85996)
Events (91319)
Executive appointments (147)
FDA (15005)
Florida (239)
Funding (120)
Gene therapy (85)
Georgia (59)
GLP-1 (489)
Government (4404)
Healthcare (18210)
Hotbed/Location (413756)
Idaho (56)
Illinois (261)
Indiana (130)
Infectious disease (2497)
Inflammatory bowel disease (89)
Interviews (522)
IPO (14510)
Job creations (3427)
Job search strategy (1942)
Kansas (86)
Layoffs (422)
Legal (6538)
Lung cancer (98)
Manufacturing (72)
Maryland (342)
Massachusetts (1157)
Medical device (12347)
Medtech (12352)
Mergers & acquisitions (17792)
Metabolic disorders (216)
Michigan (121)
Minnesota (178)
Neuroscience (1221)
New Jersey (511)
New York (498)
NextGen Class of 2024 (6378)
Non-profit (4497)
North Carolina (589)
Northern California (720)
Obesity (128)
Ohio (96)
Opinion (195)
Patents (65)
Pennsylvania (491)
People (58128)
Phase I (18739)
Phase II (26452)
Phase III (19353)
Pipeline (99)
Postmarket research (2521)
Preclinical (8041)
Press Release (67)
Rare diseases (127)
Real estate (5979)
Recruiting (60)
Regulatory (19333)
Research institute (2388)
Resumes & cover letters (403)
South America (1170)
Southern California (651)
Startups (3335)
Texas (210)
United States (7345)
Vaccines (453)
Washington State (235)
Weight loss (110)
Date
Today (165)
Last 7 days (634)
Last 30 days (1998)
Last 365 days (33894)
2024 (23402)
2023 (36417)
2022 (46702)
2021 (51646)
2020 (50922)
2019 (45031)
2018 (34360)
2017 (30841)
2016 (30223)
2015 (35604)
2014 (28520)
2013 (25116)
2012 (26406)
2011 (26741)
2010 (25313)
630,020 Results for "university of washington".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Interventional DiviTum(R) TKa Trial Launches at Washington University
Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.
March 13, 2024
·
2 min read
Biotech Bay
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
Guardant Health, Inc. (Nasdaq: GH) announced its research collaborators from Washington University’s Siteman Cancer Center will lead an oral presentation today at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting highlighting the potential role of liquid biopsy in addressing racial inequities in enrollment in clinical trials and in the use of targeted therapies for advanced breast cancer.
June 3, 2024
·
5 min read
Job Trends
5 Top Companies Hiring in the Washington, D.C., Area
Looking for a biopharma job in or near Washington, D.C.? Check out these five top companies hiring life sciences professionals like you.
June 26, 2024
·
1 min read
·
Angela Gabriel
Biotech Bay
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Vaxart, Inc. announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024.
March 27, 2024
·
1 min read
BioMidwest
Mill Creek’s Frontier Dermatology Is First in Washington to Offer Nonsurgical Treatment for Common Skin Cancer Using Image-Guided Superficial Radiation Therapy
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy, a nonsurgical treatment with the highest cure rate for common skin cancers, announced its availability in Washington at an event at Frontier Dermatology in Mill Creek.
April 17, 2024
·
3 min read
Press Releases
Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
September 5, 2024
·
6 min read
Biotech Bay
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week 2024 in Washington D.C. from May 18th to May 21st.
May 7, 2024
·
6 min read
Press Releases
MedStar Washington Hospital Center Ranks Among Nation’s Best Hospitals and Shares the #1 Spot in the Washington Region
July 17, 2024
·
3 min read
Drug Development
MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart Patient Treated at MedStar Washington Hospital Center
The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.
May 2, 2024
·
2 min read
Press Releases
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
August 15, 2024
·
2 min read
1 of 63,002
Next